Interaction Checker

Add peptides or compounds to check all pairwise interactions, cumulative organ load, and safety flags.

Elevated gonads load from LGD-4033, RAD-140. Monitor this organ system closely.

Elevated liver load from LGD-4033, RAD-140. Monitor this organ system closely.

Cumulative Organ Load

Gonads

elevated

Liver

elevated

Heart

moderate

Shared Safety Flags

2x 2 androgenic compounds (LGD-4033, RAD-140). Additive androgenic load — increased risk of hair loss, acne, prostate effects.

2x 2 compounds raise blood pressure (LGD-4033, RAD-140). Monitor BP daily and consider cardiovascular support.

2x 2 compounds share the carcinogenic-risk safety flag (LGD-4033, RAD-140). Monitor accordingly.

2x 2 hepatotoxic compounds (LGD-4033, RAD-140). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.

2x 2 HPTA-suppressive compounds (LGD-4033, RAD-140). Deep hormonal shutdown expected — plan extended PCT.

2x 2 compounds disrupt lipids (LGD-4033, RAD-140). Get lipid panel mid-cycle — consider adding lipid support.

LGD-4033 + RAD-140

Monitor

Stacking LGD-4033 with RAD-140 compounds the suppression of the HPG axis and increases the risk of liver enzyme elevation and lipid disruption. While some users combine these two SARMs, the additive suppression makes post-cycle recovery significantly more difficult without proportional additional benefit. If this combination is used, a testosterone base and comprehensive blood work monitoring are strongly advised. Most experienced users recommend choosing one SARM per cycle rather than stacking.

Researched 90% confidence Compare

Interaction data is compiled from research literature, pharmacological analysis, and community reports. Inferred interactions are based on known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.